Despite a stronger-than-guided revenue, Bastide’s improvement in the underlying operating profit is limited by the weaker pricing in the UK respiratory business. Its outlook for next year seems rather prudent but is expected to be uplifted subject to potential external growth.

19 Oct 2021
Prudent outlook hoping to be uplifted by M&A
-
-
-
Yi Zhong
-
3 pages
-

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Prudent outlook hoping to be uplifted by M&A
- Published:
19 Oct 2021 -
Author:
Yi Zhong -
Pages:
3 -
Despite a stronger-than-guided revenue, Bastide’s improvement in the underlying operating profit is limited by the weaker pricing in the UK respiratory business. Its outlook for next year seems rather prudent but is expected to be uplifted subject to potential external growth.